ResearchNEO

NEO: FY25 Deep Dive

Ddrillr ResearchOriginal research

Published Sep 3, 20261 min read

NeoGenomics FY25 at $727M. NI $-108M; EPS $-4.20. Diagnostics.

FY25 revenue $727M; OI $-66M; NI $-108M; EPS $-4.20.

NeoGenomics FY25 (Dec 31, 2025) at $727M revenue. OpInc $-66M; NI $-108M; EPS $-4.20. Diagnostics.

Companies in this article